Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PCT-guided antibiotic treatment for hospitalized acute COPD exacerbations
NL-OMON55985Recruiting
- Sponsor
- Erasmus MC
- Start
- Aug 2021
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of prednisolone and amoxicillin + clavulanate in chronic obstructive pulmonary disease (COPD) (2 arms), sponsored by Erasmus MC. Primary endpoint: Treatment failure at day 30. Started Aug 2021; status: recruiting.
02
Drugs
prednisoloneamoxicillin + clavulanate
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NL-OMON55985.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON55985.